| 168.51 0.13 (0.08%) | 07-31 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 199.38 | 1-year : | 232.88 |
| Resists | First : | 170.71 | Second : | 199.38 |
| Pivot price | 160.25  |
|||
| Supports | First : | 154.11 |
Second : | 143.86 |
| MAs | MA(5) : | 166.13 |
MA(20) : | 159.07 |
| MA(100) : | 136.2 |
MA(250) : | 136.17 |
|
| MACD | MACD : | 5.5 |
Signal : | 5 |
| %K %D | K(14,3) : | 85.3 |
D(3) : | 85 |
| RSI | RSI(14): 67.3 |
|||
| 52-week | High : | 170.71 | Low : | 107 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.[ ICUI ] has closed below upper band by 7.1%. Bollinger Bands are 7.4% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 169.92 - 170.42 | 170.42 - 170.98 |
| Low: | 164.23 - 164.85 | 164.85 - 165.54 |
| Close: | 167.42 - 168.35 | 168.35 - 169.4 |
ICU Medical, Inc., operating globally through its subsidiaries, is a medical technology firm that specializes in the development, manufacture, and sale of devices for both infusion therapy and critical care. Their extensive product line for infusion therapy encompasses: Needlefree Connectors: Such as the MicroClave, MicroClave Clear, and NanoClave brands. Catheter Maintenance & Disinfection: Including Neutron patency devices and SwabCap/SwabTip disinfecting caps. Hemodialysis Solutions: Like Tego connectors and ClearGuard HD antimicrobial caps. Hazardous Drug Handling: With closed system transfer devices (ChemoClave, ChemoLock) and the Diana compounding system for safe preparation. They also provide a comprehensive range of intravenous (IV) solutions, diluents, and irrigation fluids, available in diverse packaging options like flexible containers and pour bottles. These include common formulations such as sodium chloride, dextrose, balanced electrolytes, lactated ringer's, mannitol, and sterile water, alongside specialized irrigation solutions like acetic acid and glycine. In medication management, ICU Medical offers sophisticated infusion pumps, including the Plum 360 and LifeCare PCA brands. Its advanced ICU Medical MedNet software enhances medication safety by integrating smart pumps with hospital electronic health records (EHRs), asset tracking, and alarm notification platforms. Accompanying professional services are also provided. For critical care environments, their portfolio features: Hemodynamic Monitoring: Systems like Cogent 2-in-1 and CardioFlo. Cardiac Output & Oximetry: TDQ, OptiQ, and TriOx catheters. Blood Pressure Transducers: Such as Transpac. Blood Sampling Systems: Including the SafeSet closed blood sampling and conservation systems. The company distributes its products to a wide spectrum of healthcare providers, including acute care hospitals, wholesalers, ambulatory clinics, and various alternate site facilities such as outpatient clinics, home healthcare services, and long-term care centers. Established in 1984, ICU Medical maintains its headquarters in San Clemente, California.
Fri, 31 Jul 2026
ICU Medical Inc (ICUI) Valuation: PE, PB & Fair Value Analysis - TradingKey
Wed, 29 Jul 2026
ICUI|ICU Medical Inc|Price:169.747|Chg%:+3.217 - TradingKey
Thu, 23 Jul 2026
ICU Medical Announces Timing of Second Quarter 2026 Earnings Release and Conference Call - Quiver Quantitative
Thu, 23 Jul 2026
ICU Medical Announces Time of Second Quarter 2026 Earnings Conference Call - GlobeNewswire
Mon, 20 Jul 2026
ICU Medical (ICUI) Expands Austin IV Capacity, Is The Stock Already Pricey? - Sahm
Thu, 09 Jul 2026
ICU Medical Inc (ICUI) Stock Up 3.2% but GF Value Says Overvalued -- GF Score: 80/100 - GuruFocus
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Instruments & Supplies
|
|
| Shares Out | 25 (M) |
| Shares Float | 25 (M) |
| Held by Insiders | 1.9 (%) |
| Held by Institutions | 114.8 (%) |
| Shares Short | 1,830 (K) |
| Shares Short P.Month | 1,770 (K) |
| EPS | 1.86 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 84.5 |
| Profit Margin | 2.1 % |
| Operating Margin | 5.7 % |
| Return on Assets (ttm) | 1.6 % |
| Return on Equity (ttm) | 2.2 % |
| Qtrly Rev. Growth | -12.4 % |
| Gross Profit (p.s.) | 32.73 |
| Sales Per Share | 86.43 |
| EBITDA (p.s.) | 12.46 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 167 (M) |
| Levered Free Cash Flow | 387 (M) |
| PE Ratio | 90.59 |
| PEG Ratio | 0 |
| Price to Book value | 1.99 |
| Price to Sales | 1.94 |
| Price to Cash Flow | 25.15 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|